Franco Moscetti - DiaSorin SpA Independent Director
| DSRLF Stock | USD 88.45 0.00 0.00% |
Director
Mr. Franco Moscetti has served as Independent Director of Diasorin S.p.A. since March 26, 2007. He also serves as Chairman of the Audit and of the Nominating Committees of the Company. He also serves as Coordinator of the Committee for Transactions with Related Parts within the Company. He started his professional career in 1973, at Air Liquide Group. In 1989, he was appointed General Manager at Vitalaire Italia. In 1995, was appointed as General Manager and Chief Executive Officer of Air Liquide Sanita. Currently, he serves as Director at Touring Club Italiano and Fideuram Investimenti SGR SpA and as Chief Executive Officer and General Manager of Amplifon SpA. since 2007.
| Age | 66 |
| Tenure | 17 years |
| Phone | 39 01 614871 |
| Web | https://diasoringroup.com |
DiaSorin SpA Management Efficiency
The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Glenn Muir | Neuronetics | 59 | |
| Jeffrey Cossman | Precipio | N/A | |
| Ronald Lehman | Fonar | 41 | |
| Ronald Hunt | Neuronetics | 52 | |
| Douglas Fisher | Precipio | 39 | |
| Mark Rimer | Precipio | 35 | |
| Mark Burnett | ProPhase Labs | 56 | |
| Jason Barr | ProPhase Labs | 36 | |
| Samuel Riccitelli | Precipio | 58 | |
| Michael Sherman | RadNet Inc | 74 | |
| Marvin Cadwell | RadNet Inc | 73 | |
| Lawrence Levitt | RadNet Inc | 74 | |
| Charles OData | Fonar | 82 | |
| Wilfred Jaeger | Neuronetics | 62 | |
| Michael Luther | Precipio | 58 | |
| James McCubbin | ProPhase Labs | 51 | |
| Mark Leventhal | ProPhase Labs | 55 | |
| Norman Hames | RadNet Inc | 68 | |
| David Swartz | RadNet Inc | 73 | |
| Stephen Campe | Neuronetics | 53 | |
| Robert Janoff | Fonar | 90 | |
Management Performance
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 |
DiaSorin SpA Leadership Team
Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francesca Pasinelli, Independent Director | ||
| Vittorio Squarotti, Non-Executive Director | ||
| Francesco Colotta, Senior Corporate Vice President and Chief Medical Officer | ||
| Riccardo Fava, Director of Investor Relations and Corporate Communication | ||
| Maria Landini, Non-Executive Director | ||
| Giuseppe Alessandria, Lead Independent Director | ||
| Roberta Somati, Independent Director | ||
| Antonio Boniolo, Non-Executive Director | ||
| Gustavo Denegri, Non-Executive Chairman of the Board | ||
| Carlo Rosa, CEO, General Manager and Executive Director | ||
| Fiorella Altruda, Independent Director | ||
| Monica Tardivo, Independent Director | ||
| John Eskdale, President DiaSorin Inc | ||
| Angelo Rago, Pres Corp | ||
| Pier Angelis, CFO, Sr. Corporate VP and Corporate Accounting Documents Officer | ||
| Ezio Garibaldi, Non-Executive Director | ||
| Michele Denegri, Non-Executive Vice Chairman of the Board | ||
| Giancarlo Boschetti, Non-Executive Director | ||
| Piergiorgio Pedron, Senior Corporate VP and CFO | ||
| Ulisse Spada, Mang Department | ||
| Tullia Todros, Independent Director | ||
| Stefano Ronchi, Sr. Corporate VP of HR | ||
| Eva Desana, Non-Executive Director | ||
| Enrico Amo, Non-Executive Director | ||
| Stefano Altara, Director | ||
| Franco Moscetti, Independent Director | ||
| Fabrizio Bonelli, Chief Officer | ||
| Ugo Gay, Sr Operations | ||
| Chen Even, Chief Commercial Officer and Executive Director |
DiaSorin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 8.64 B | |||
| Shares Outstanding | 53.84 M | |||
| Shares Owned By Insiders | 57.50 % | |||
| Shares Owned By Institutions | 22.36 % | |||
| Price To Earning | 26.36 X | |||
| Price To Book | 4.73 X |
Pair Trading with DiaSorin SpA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DiaSorin SpA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaSorin SpA will appreciate offsetting losses from the drop in the long position's value.Moving against DiaSorin Pink Sheet
| 0.82 | GE | GE Aerospace Earnings Call This Week | PairCorr |
| 0.81 | LZAGY | Lonza Group AG Earnings Call Today | PairCorr |
| 0.8 | LZAGF | Lonza Group | PairCorr |
| 0.62 | DHR | Danaher Earnings Call This Week | PairCorr |
| 0.57 | IQV | IQVIA Holdings Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to DiaSorin SpA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DiaSorin SpA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DiaSorin SpA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DiaSorin SpA to buy it.
The correlation of DiaSorin SpA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DiaSorin SpA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DiaSorin SpA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DiaSorin SpA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaSorin SpA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for DiaSorin Pink Sheet analysis
When running DiaSorin SpA's price analysis, check to measure DiaSorin SpA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaSorin SpA is operating at the current time. Most of DiaSorin SpA's value examination focuses on studying past and present price action to predict the probability of DiaSorin SpA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaSorin SpA's price. Additionally, you may evaluate how the addition of DiaSorin SpA to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |